Michigan Technological University
Dissecting the Role of Selenoprotein P and Thioredoxin Reductase in Pancreatic Cancer Metabolism
Abstract
dc:description.abstractPancreatic ductal adenocarcinoma (PDAC), the fourth leading cause of US cancer-related deaths, has a stark 5-year survival rate of 9%, emphasizing an urgent need for effective therapies. A well-established characteristic of cancer, metabolic dysregulation, presents an opportunity for developing therapies that target specific metabolic susceptibilities inherent in cancer cells. Our recent studies have discovered a susceptibility in PDAC; deprivation of cystine or blocking its uptake by erastin (a cystine transport inhibitor) triggers significant lipid peroxidation, thereby inducing ferroptosis specifically in the mesenchymal subtype of PDAC, but not in the epithelial subtype. This study aims to elucidate the roles of Selenoprotein P (Sepp1) and Thioredoxin Reductase (TrxR) in epithelial PDAC. Using RNAi and CRISPR-CAS9 methodologies, we found that the activity of TrxR2 is responsible for drug resistance in epithelial PDAC, while Sepp1 and TrxR1 are unnecessary. These findings could significantly contribute to novel therapeutic developments.
Degree
thesis:*- Name thesis:degree_name
- Master of Science in Biological Sciences (MS)
- Level thesis:degree_level
- Open Access Master's Report
- Discipline thesis:degree_discipline
- Department of Biological Sciences
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Abbas, Alyssa A.
- Committee members dc:contributor.committeemember
-
- Paul Goetsch
- Stephen Techtmann
- Contributors dc:contributor
-
- Xiaohu Tang
Subjects
dc:subject × 7Identifiers
dc:identifier.*- Identifier
- https://digitalcommons.mtu.edu/etdr/1618